Skip to main content
OpenTrials

Clinical trial condition

Vector Borne Diseases

Explore clinical trials studying Vector Borne Diseases. Study availability and eligibility vary by location and protocol.

2,038 public trials 146 recruiting studies
Refine in advanced search Browse all conditions

Vector Borne Diseases trial results

Recruiting

A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population

NCT07103148

Conditions
Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +8 more
Locations
  • Investigational Site Number : 3400001 San Pedro Sula, Honduras
  • Investigational Site Number : 3400005 San Pedro Sula, Cortes, Honduras
  • Investigational Site Number : 3400002 Tegucigalpa, Honduras
  • Investigational Site Number : 3400003 Tegucigalpa, Honduras
View all 13 locations
View Trial Details
Recruiting

A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine

NCT07500506

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +6 more
Locations
  • Northern Light Eastern Maine Medical Center Bangor, Maine, United States
  • Northern Light Family Medicine and Residency Center Bangor, Maine, United States
  • University of Massachusetts Chan Medical School Worcester, Massachusetts, United States
  • Hunterdon Medical Center Flemington, New Jersey, United States
View all 22 locations
View Trial Details
Recruiting

A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.

NCT07555392

Conditions
Active Immunisation for Chikungunya Virus Infection, Alphavirus Infections, Arbovirus Infections, +7 more
Locations
  • All India Institute of Medical Sciences Guwahati, Assam, India
  • All India Institute of Medical Sciences Patna, Bihar, India
  • All India Institute of Medical Sciences Raipur, Chhattisgarh, India
  • Redkar Hospital and Research Centre Mumbai, Goa, India
View Trial Details
Recruiting

A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)

NCT06579755

Conditions
Arbovirus Infections, Dengue, Dengue Fever, +8 more
Locations
  • Fundacion Huesped - PPDS Buenos Aires, Argentina
  • Associacao Obras Sociais Irma Dulce Hospital Santo Antonio Salvador, Estado de Bahia, Brazil
  • Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS São José do Rio Preto, São Paulo, Brazil
  • Singapore General Hospital (SGH) Singapore
View Trial Details

Related conditions